Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

Strive Health, the national leader in value-based kidney care, announced today that it has expanded its executive team.

Glen Tullman, the CEO of Transcarent, is taking another big shot at transforming the U.S. health care system.

As one of Elevance Health’s Diversity ... With more than a decade of leadership experience, Evan has a strong background in company building, high technology product development and enterprise ...

Prior to his current role, Gray was the inaugural chief health equity officer at Elevance Health Inc. and was an associate ... Gray’s combined medical expertise and educational background prepared him ...

A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...